Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $7.97 in the prior trading day, Anavex Life Sciences Corporation (NASDAQ: AVXL) closed at $7.74, down -2.89%. In other words, the price has decreased by -$2.89 from its previous closing price. On the day, 1.66 million shares were traded. AVXL stock price reached its highest trading level at $7.938 during the session, while it also had its lowest trading level at $7.47.
Ratios:
Our goal is to gain a better understanding of AVXL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.93 and its Current Ratio is at 8.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 664818240 and an Enterprise Value of 563654272.
Stock Price History:
The Beta on a monthly basis for AVXL is 0.92, which has changed by 0.035064936 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $6.50. The 50-Day Moving Average of the stock is -14.21%, while the 200-Day Moving Average is calculated to be -16.01%.
Shares Statistics:
The stock has traded on average 1.11M shares per day over the past 3-months and 1044720 shares per day over the last 10 days, according to various share statistics. A total of 85.41M shares are outstanding, with a floating share count of 82.98M. Insiders hold about 3.40% of the company’s shares, while institutions hold 38.17% stake in the company. Shares short for AVXL as of 1760486400 were 26617983 with a Short Ratio of 23.97, compared to 1757894400 on 24840667. Therefore, it implies a Short% of Shares Outstanding of 26617983 and a Short% of Float of 32.04.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 3.0 analysts currently analyzing and rating the stock of Anavex Life Sciences Corporation (AVXL).The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.56 and -$0.59 for the fiscal current year, implying an average EPS of -$0.58. EPS for the following year is $1.41, with 3.0 analysts recommending between $5.23 and -$0.51.
